Check out our COVID-19 dedicated page for tenders related to medical equipment needs.
231901-2021 - Belgium-Brussels: Production, Priority-purchasing Options and Supply of Covid-19 Vaccines, Including Adapted Vaccines to SARS-CoV-2 Variants and Paediatric Formulations of such Vaccines for EU Member States
Sweden-Östersund: Research and experimental development services
Prior information notice
This notice is for prior information only
Section I: Contracting authority
This PCP is carried out by Jämtlands Läns Landsting, lead procurer acting in the name and on behalf of the buyers group listed in I.1). The applicable national procurement law is Swedish law.
Section II: Object
Pre-commercial Procurement of innovative ICT-enabled Integrated Care Solutions to Advance Multidisciplinary Health and Care for Patients with Chronic Heart Failure
This PIN provides early information about the expected starting date and purchase volume for a pre-commercial procurement (PCP), and about the open market consultation that is currently in preparation of this procurement. More information about the upcoming open market consultation is provided in section II.2.14).
Within the framework of the INCAREHEART project, the procurement aims to procure R&D services in the form of a solution that provides innovative ICT-enabled integrated care solutions to advance multidisciplinary health and care for patients with chronic heart failure (CHF). The procurement is intended to address the unmet needs of the procurers in relation to various aspects (building blocks) of continous management and seamless transitions of care for CHF patients:
(a) early diagnosis and anticipatory care;
(b) care and follow-up;
(c) living with heart failure.
All interested operators are invited to take part in this OMC (regardless of their geographic location, their size or governance structure).
Information about testing location is included under II.2.4).
Procurement will take the form of pre-commercial procurement (PCP), where R&D service contracts will be awarded in parallel to different R&D providers in a phased approach. This will allow alternative, competing solutions to be compared. Each selected supplier will receive a framework contract covering three R&D phases.
The three phases are: solution design, prototype development, original development and validation and testing of a limited volume of the first products or services. After each phase, interim evaluations are conducted to progressively select the best of the competing solutions. The contractors with the best quality and value for money solutions will be offered a specific contract for the next phase. Price will not be the only award criterion and all criteria will be stated only in the procurement documents.
All interested operators are invited to take part in the upcoming open market consultation (regardless of their geographic location, the size or governance structure of their organisation). The open market consultation will be organised in the form of a series of meetings. It will provide you with an overview of the procurement objectives, the PCP process and the main clauses of the contract. You will also have the opportunity to ask questions. The first series of meetings will be held online by each of the procurers mentioned under Section I.1). During those meetings, the procurers will offer presentations in their own local languages, namely Turkish, Italian, Greek, and Portuguese, except Region Jämtland that will conduct the event in English. These meetings are planned to take place in June 2021: 10th Jämtland, 15th Turkey, 15th Naples, 17th Thessaloniki, 18th Lisbon. The meetings will be followed by an additional international online event, 29 June 2021, in English. Registration and agenda for these meetings will be announced on the website https:/incareheart.eu/ on 27 April 2021. Interested participants are encouraged to subscribe to the project mailing list, embedded at the bottom of the website, to stay tuned about project updates.
The procurement is expected to start in spring 2022 and end in summer 2024.
Testing is expected to take place in Sweden (Regions Jämtland Härjedalen and Västerbotten), Greece (Thessaloniki), Italy (Naples and Salerno), Portugal (Amadora), and Turkey (Istanbul). This testing may also serve as a first customer test reference for the contractors.
The selected suppliers will retain ownership of the intellectual property rights (IPRs) they generate during the PCP and will be able to use them to exploit the full market potential of the solutions developed, i.e. beyond the procurement.
This procurement is funded by the European Union's Horizon 2020 Research and Innovation Programme under Grant Agreement No 965134 — INCAREHEART (https://incareheart.eu/). The EU has awarded a grant for this procurement but is not participating as a contracting authority in the procurement.
Estimated total value: EUR 4 650 000 incl. VAT, if applicable.
You can participate in the PCP call for tender even if you did not participate in the OMC.
All information provided during the OMC and other background will be published in English on our website https:/incareheart.eu/.
Offers will be accepted in English. All communication regarding this PCP will be carried out in English.
Section IV: Procedure
Section VI: Complementary information
The PCP procurement is exempted from the WTO Government Procurement Agreement (GPA), the EU public procurement directives and the national laws that implement them (because it concerns the procurement of R&D services where the benefits do not accrue exclusively to the contracting authority for its use in the conduct of its own affairs). This PIN is published to announce an open market consultation on a future procurement procedure. The PIN is not a commitment to procure.